Nkc Diagnostics & Research Centre Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 31-05-2024
- Paid Up Capital ₹ 1.00 M
as on 31-05-2024
- Company Age 7 Year, 8 Months
- Last Filing with ROC 31 Mar 2019
- Satisfied Charges ₹ 11.16 M
as on 31-05-2024
About Nkc Diagnostics & Research Centre
The Company is engaged in the Non-Profit Organizations Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company has closed loans amounting to ₹1.12 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Chaitali Nimbalkar, Manjeet Kulkarni, and Preeti Chinchanikar serve as directors at the Company.
- CIN/LLPIN
U85310PN2017PTC167950
- Company No.
167950
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Jan 2017
- Date of AGM
30 Sep 2019
- Date of Balance Sheet
31 Mar 2019
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Kolhapur, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Nkc Diagnostics & Research Centre?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Manjeet Kulkarni  | Director | 13-Jan-2017 | Current |
| Chaitali Nimbalkar | Director | 13-Jan-2017 | Current |
| Preeti Chinchanikar | Director | 13-Jan-2017 | Current |
Financial Performance and Corporate Structure Insights of Nkc Diagnostics & Research Centre.
Enhance accessibility to Nkc Diagnostics & Research Centre's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Nkc Diagnostics & Research Centre?
Unlock access to Nkc Diagnostics & Research Centre's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Radplus Diagnostics And Healthcare Private Limited
Active
1 year 8 months Manjeet Kulkarni and Preeti Chinchanikar are mutual person
Eighth Axis Diagnosis And Healthcare Cen Tre Llp
Active 3 years 10 months Manjeet Kulkarni is a mutual person
Ninth Axis Diagnosis And Healthcare Centre Llp
Active 3 years 9 months Manjeet Kulkarni is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 31 May 2017 | ₹1.12 Cr | Satisfied |
How Many Employees Work at Nkc Diagnostics & Research Centre?
Unlock and access historical data on people associated with Nkc Diagnostics & Research Centre, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nkc Diagnostics & Research Centre, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nkc Diagnostics & Research Centre's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
